Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer.

Bibliographic Details
Title: Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer.
Authors: Xiao-li Wei, Miao-zhen Qiu, Huan-xin Lin, Ying Zhang, Jian-xin Liu, Hong-mei Yu, Wei-ping Liang, Ying Jin, Chao Ren, Ming-ming He, Wei-wei Chen, Hui-yan Luo, Zhi-qiang Wang, Dong-sheng Zhang, Feng-hua Wang, Yu-hong Li, Rui-hua Xu
Source: PLoS ONE, Vol 9, Iss 3, p e89965 (2014)
Publisher Information: Public Library of Science (PLoS), 2014.
Publication Year: 2014
Collection: LCC:Medicine
LCC:Science
Subject Terms: Medicine, Science
More Details: BackgroundMetabolic syndrome and/or its components have been demonstrated to be risk factors for several cancers. They are also found to influence survival in breast, colon and prostate cancer, but the prognostic value of metabolic syndrome in gastric cancer has not been investigated.MethodsClinical data and pre-treatment information of metabolic syndrome of 587 patients diagnosed with early stage gastric cancer were retrospectively collected. The associations of metabolic syndrome and/or its components with clinical characteristics and overall survival in early stage gastric cancer were analyzed.ResultsMetabolic syndrome was identified to be associated with a higher tumor cell differentiation (P=0.036). Metabolic syndrome was also demonstrated to be a significant and independent predictor for better survival in patients aged >50 years old (P=0.009 in multivariate analysis) or patients with proximal gastric cancer (P=0.047 in multivariate analysis). No association was found between single metabolic syndrome component and overall survival in early stage gastric cancer. In addition, patients with hypertension might have a trend of better survival through a good control of blood pressure (P=0.052 in univariate analysis).ConclusionsMetabolic syndrome was associated with a better tumor cell differentiation in patients with early stage gastric cancer. Moreover, metabolic syndrome was a significant and independent predictor for better survival in patients with old age or proximal tumors.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1932-6203
Relation: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089965&type=printable; https://doaj.org/toc/1932-6203
DOI: 10.1371/journal.pone.0089965&type=printable
DOI: 10.1371/journal.pone.0089965
Access URL: https://doaj.org/article/5f3cc11bd6be4252bba2d31021a4ebce
Accession Number: edsdoj.5f3cc11bd6be4252bba2d31021a4ebce
Database: Directory of Open Access Journals
More Details
ISSN:19326203
DOI:10.1371/journal.pone.0089965&type=printable
Published in:PLoS ONE
Language:English